Last update 30 Mar 2025

RD-0605

Overview

Basic Info

Drug Type
CAR-T
Synonyms
Targeted CD19/BCMA CAR-T Therapy( Nanjing Bioheng Biotech), RD06-05
Target
BCMA x CD19
Action
modulators
Mechanism
BCMA modulators(B-cell maturation protein modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [7]
Active Indication
Churg-Strauss SyndromeGranulomatosis With PolyangiitisIdiopathic Inflammatory Myopathies+ [5]
Inactive Indication-
Originator Organization
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
Active Organization
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RD-0605
NCT06775912
/ RecruitingEarly Phase 1
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
100 Clinical Results associated with RD-0605
Login to view more data
100 Translational Medicine associated with RD-0605
Login to view more data
100 Patents (Medical) associated with RD-0605
Login to view more data
100 Deals associated with RD-0605
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Churg-Strauss SyndromePhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Granulomatosis With PolyangiitisPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Idiopathic Inflammatory MyopathiesPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Microscopic PolyangiitisPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Multiple SclerosisPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Neuromyelitis OpticaPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Scleroderma, DiffusePhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Systemic Lupus ErythematosusPhase 1
China
Nanjing Bioheng Biotech Co., Ltd.Nanjing Bioheng Biotech Co., Ltd.Startup
15 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free